| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |